Vorolanib + Atezolizumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
A phase 2 trial of Vorolanib and Atezolizumab in Extensive-stage small-cell lung cancer, run by Washington University School of Medicine, recorded as terminated on the registry.
Overview
Vorolanib + Atezolizumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer is a phase 2 interventional study registered as NCT04373369 by Washington University School of Medicine, with 11 participants recorded, started 2020-10-07 and due to reach its primary completion in 2022-08-18. Interventions recorded: Vorolanib, Atezolizumab. Conditions recorded: Extensive-stage Small Cell Lung Cancer.
Linked to the drug Vorolanib because the registry names it among its interventions and Extensive-stage small-cell lung cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialVorolanib Monotherapy or in Combination With Toripalimab as Adjuvant Therapy for Patients With Intermediate-high Risk of Recurrence in Renal Cell Carcinoma
Shares Vorolanib and the tag pipeline.
- TrialVorolanib Plus Sintilimab for Advanced Renal Cell Carcinoma After Failure of Prior Immune Checkpoint Inhibitors Based Combination Therapy
Shares Vorolanib and the tag pipeline.
- TrialSNB-101 for Treatment of Extensive Stage Small Cell Lung Cancer
Shares Extensive-stage small-cell lung cancer and the tag pipeline.
- TrialPembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008/KEYVIBE-008)
Shares Extensive-stage small-cell lung cancer, Atezolizumab and the tag pipeline.
- TrialA Single-arm, Open-label, Phase II Study to Evaluate Efficacy, Safety and Pharmacokinetics of HLX10 + Chemotherapy in Patients With ES-SCLC
Shares Extensive-stage small-cell lung cancer and the tag pipeline.
- TrialA Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)
Shares Atezolizumab and the tag pipeline.
- TrialA Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
Shares Atezolizumab and the tag pipeline.
- TrialA Study of YL201 in Patients With Advanced Solid Tumors
Shares Atezolizumab and the tag pipeline.